Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Cash & Current Investments: 2023-2025

Historic Cash & Current Investments for Basel Medical (BMGL) over the last 3 years, with Q2 2025 value amounting to $2.3 million.

  • Basel Medical's Cash & Current Investments rose 6242.07% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year increase of 5870.66%. This contributed to the annual value of $2.3 million for FY2025, which is 6182.24% up from last year.
  • As of Q2 2025, Basel Medical's Cash & Current Investments stood at $2.3 million, which was up 6242.07% from $5.4 million recorded in Q4 2024.
  • In the past 5 years, Basel Medical's Cash & Current Investments ranged from a high of $5.4 million in Q4 2024 and a low of $901754.5 during Q4 2023
  • In the last 3 years, Basel Medical's Cash & Current Investments had a median value of $1.9 million in 2025 and averaged $2.5 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 50436.35% in 2024, then soared by 6242.07% in 2025.
  • Over the past 3 years, Basel Medical's Cash & Current Investments (Quarter) stood at $901754.5 in 2023, then surged by 504.36% to $5.4 million in 2024, then plummeted by 57.02% to $2.3 million in 2025.
  • Its Cash & Current Investments was $2.3 million in Q2 2025, compared to $5.4 million in Q4 2024 and $1.4 million in Q2 2024.